[Tricuspid Valve Disease - Evaluation and Management in Clinical Practice]

Tricuspid valve disease encompasses a spectrum of conditions, among which tricuspid regurgitation is the most prevalent and clinically significant. Affected patients are typically elderly and present with systemic congestion, impaired renal and hepatic function, and reduced quality of life. Echocardiography enables mechanistic classification, severity grading, and assessment of right ventricular function. While medical therapy remains foundational, transcatheter interventions - including edge-to-edge repair and valve replacement - have emerged as options for high-risk patients. Randomized trials demonstrate improvements in symptoms and quality of life, with emerging evidence for reductions in heart failure hospitalizations. This article provides a practice-oriented overview of diagnosis, management, and referral pathways for tricuspid valve disease, including rarer entities such as tricuspid stenosis, endocarditis, and carcinoid heart disease.